Humanigen Inc (HGENQ)

[Corundum]

I would not be too nervous about this Chinese company's "trial". 588 patients enrolled in Brazil in 3 weeks ending Feb. 22, top line data readout in a few days or hours after last 14-day patient treatment, placebo arm with 47% mortality rate in 14 days says the trial sites were awful, their drug was given for 14 straight days, then the readout was at 14 days, with no followup if their patients reverted without more meds or died later, etc, etc.